Bausch + Lomb Corporation
NYSE:BLCOMedical - Instruments & Supplies
+$0.04 today
- Market cap
- $7.49B
- Beta
- 0.57
- P/E (TTM)
- -24.2
- EPS (TTM)
- -$0.62
Volume 0.51M
Average 0.46M
BLCO Deferred Revenue
Payments received for goods or services the company will deliver within the next year.
Bausch + Lomb CorporationNYSE: BLCO
Deferred Revenue · Q2 FY2026 · quarter ended Jun 2026
Deferred revenue remains negative
Q2 FY2026 deferred revenue was $0, compared with $0 a year earlier.
Context
- Deferred revenue amounted to 0.0% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
- Deferred revenue increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Deferred Revenue history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Deferred Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Deferred Revenue vs competitors
How BLCO compares with its peers on the latest reported figures
- BLCO's Jun 2026 deferred revenue of $0 is the 4th highest of the 10 companies compared; the peer median is $0.
- Deferred revenue amounts to 0.0% of total assets for BLCO, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $91.65M | +3720.3% | +373.0% | 5.3% | |
| Sep 2026 | $26.1M | -1.1% | — | 1.6% | |
| Jun 2026 | $1.19M | -87.8% | +14.7% | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Sep 2026 | $0 | — | — | — | |
| Sep 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding BLCO) | $0 | -44.5% | +193.9% | 0.0% | |
Competitors are the stored peer set for BLCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 174M | 380M | 334M | 305M | 383M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 721M | 726M | 875M | 1.03B | 1.22B |
| Inventory | 572M | 628M | 1.03B | 1.04B | 976M |
| Other Current Assets | 3M | 403M | 505M | 421M | 397M |
| Total Current Assets | 1.64B | 2.14B | 2.74B | 2.79B | 2.98B |
| Property, Plant & Equipment (Net) | 1.23B | 1.42B | 1.5B | 1.49B | 1.76B |
| Goodwill | 4.59B | 4.51B | 4.58B | 4.52B | 4.76B |
| Intangible Assets | 2.26B | 2.06B | 3.59B | 3.49B | 3.28B |
| Long-term Investments | 0 | 12M | 19M | 19M | 7M |
| Tax Assets | 933M | 927M | 921M | 885M | 934M |
| Other Non-current Assets | 180M | 84M | 92M | 275M | 303M |
| Total Non-current Assets | 9.19B | 9.01B | 10.7B | 10.68B | 11.05B |
| Total Assets | 10.82B | 11.14B | 13.44B | 13.47B | 14.02B |
| Account Payables | 239M | 317M | 522M | 389M | 388M |
| Short-term Debt | 28M | 51M | 57M | 40M | 77M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 356M | 732M | 709M | 459M | 1.46B |
| Total Current Liabilities | 1.1B | 1.3B | 1.58B | 1.74B | 1.92B |
| Long-term Debt | 0 | 2.41B | 4.53B | 4.74B | 5.17B |
| Deferred Tax Liabilities | 0 | 7M | 14M | 13M | 19M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 230M | 237M | 310M | 310M | 271M |
| Total Non-current Liabilities | 322M | 2.75B | 4.94B | 5.19B | 5.58B |
| Total Liabilities | 1.42B | 4.04B | 6.52B | 6.93B | 7.5B |
| Common Stock | 10.36B | 0 | 0 | 0 | 0 |
| Retained Earnings | 0 | 6M | (254M) | (571M) | (931M) |
| Accumulated OCI | (1.04B) | (1.26B) | (1.25B) | (1.39B) | (1.18B) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 73M | 68M | 70M | 71M | 71M |
| Total Equity | 9.4B | 7.1B | 6.92B | 6.54B | 6.52B |
| Total Debt | 140M | 2.55B | 4.68B | 4.94B | 5.37B |
| Net Debt | (34M) | 2.17B | 4.34B | 4.63B | 4.99B |
Bausch + Lomb Corporation
NYSE:BLCO
Intrinsic Alpha fair value
Locked
Current Price
$20.95
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.